Pharmacy and Pharmaceutical sciences lectures and notes by Dr. Muhammad Ali

Pharmacy and Pharmaceutical sciences lectures and notes by Dr. Muhammad Ali

Share

Pharmacy and pharmaceutical sciences

Photos from Pharmacy and Pharmaceutical sciences lectures and notes by Dr. Muhammad Ali's post 29/12/2024

Unlock Your Research Potential with the NOVA Internship Program 2025!

Research Minds presents the NOVA Research Internship Program for 2025! This 4-month program is designed to provide comprehensive research skills through engaging online classes and personalized mentorship.

📅 Program Duration: February - May 2025

📌 Last Date to Apply: January 31, 2025

🔗 Apply Now: https://lnkd.in/deVQfKjx

Program Highlights

1. Introduction to Research: Basics, ethics, and importance across disciplines.

2. Research Design & Methodology: Research questions, design types, and data collection.

3. Data Analysis & Interpretation: Statistical and qualitative analysis.

4. Research Writing: Research Proposals, review articles, and thesis writing.

5. Literature Review

6. Communication & Presentation: Academic writing and presentation skills.

7. Impact & Future Directions: Translating research into practice.

8. Special lectures on LinkedIn mastery, grant writing, CV building, Scholarships and Research fundings, and AI in Research

Meet Our Esteemed Mentors

Learn from top professionals such as Professor Dr. Syed Javaid Khurshid, CONSULTANT Organisation of Islamic Countries -COMSTECH, Head of the IBCR at Research Minds, with extensive experience in science communication and diplomacy. Meritorious Prof Dr S.M.Aqil Burney Professor at CCSIS, IoBM, Karachi, with a PhD in Data Science , from University of Strathclyde ,Dr Muhammad Hussain Habib, Registrar at Salim Habib University, offers expertise in education and academia-industry linkages. Prof. Dr. Ashraf Aly Hassan, Associate Professor at UAE University, Dr. Humaira Jamshed, Chair IRB at Habib University, Dr. Munsif Jatoi , Ph.D. in Electrical Engineering from UTP Malaysia, Dr. Zakir Khan, Postdoctoral Researcher at RCSI, specializes in pharmacovigilance and healthcare research. Dr. Ubaida Fatima, Assistant Professor at NED University of Engineering and Technology , focuses on applied mathematics and research methodologies. Dr.Nimra Mazhar , NIH D43 Fogarty PhD Fellow at Aga Khan University, specializes in pharmaceutical and health sciences research. Dr. Furqan Awan, Lecturer at UVAS, focuses on epidemiology and genomic research. Engr. Abdul Moiz, Biomedical AI Specialist, Prof. Dr. Muhammad Tanweer Khan (MTK), Microbiologist at the University of Gothenburg. Dr. Shamaila Burney , Director of Corporate Affairs at Research Minds, Dr. Samita Bai, Ph.D. , Assistant Professor at SHU, specializes in computer science. Dr. Shaheena A., Assistant Professor at SHU , Dr. Jamshed Arslan, Pharm D, PhD, MD at Research Minds, Dr. Muhammad Ali , specializes in pharmaceutics. Ms. Hoor Jamil, Head of the Foundation English Department, Engr. Muhammad Shaheer Mirza, Specialist in Biomedical AI and Neurotechnology, Ali Atif Khawaja, QAI at Abbott Pharma.

📱 For Queries: Contact us : +92 3117557150

07/10/2024

We are delighted to welcome *Dr. Muhammad Ali* as the *Chairperson of the Community Pharmacy Synergy Board* at Research Minds. Under his esteemed leadership, this board will pave the way for aspiring pharmacy students by providing hands-on *Internship opportunities at leading chain pharmacies.* Dr. Ali's vast expertise in pharmaceutics, clinical pharmacology, and drug education will not only empower students but also foster a collaborative environment where academic learning meets real-world practice. We look forward to seeing the remarkable impact he will bring to our community. *Welcome aboard, Dr. Muhammad Ali!*

03/08/2024

Registration extended 15th August 2024

*Unlock Your Research Potential with the "NOVA Research Internship Program 2024" by Research Minds!*

Join our *4-month* comprehensive program designed for aspiring researchers. Gain hands-on experience, personalized mentorship, and opportunities to publish your work in HEC-approved journals.

🌟 *Modules include:* Research Articles writing, Review Articles, Research Proposals, Literature Review, Data Analysis, Grant Writing, Career Development in Research, and more.
🌟 *Our respected mentors are:* Dr. Syeda Sadaf Akber, Dr. Mudassar Azhar, Dr. Munsif Ali Jatoi, Dr. Muhammad Ali, Dr. Nimra Mazhar
🌟 *Highlights:* Publication opportunities, symposiums, personalized feedback, certification, and abstract book publication.

Who can participate: MBBS, BDS, PHARM D, DPT, B.Sc, M.Sc, M.Phil, Ph.D, and allied health science students.

📆 Deadline: August 5, 2024
🎓 Program Start: August 9, 2024

📍 Early Bird Registration Available!
📍 Apply Now: https://forms.gle/atED2JKsKYBqXtce8

For queries, contact us on WhatsApp: +92303-3256166

10/07/2024

*Unlock Your Research Potential with the "NOVA Research Internship Program 2024" by Research Minds!*

Join our *4-month* comprehensive program designed for aspiring researchers. Gain hands-on experience, personalized mentorship, and opportunities to publish your work in HEC-approved journals.

🌟 *Modules include:* Research Articles writing, Review Articles, Research Proposals, Literature Review, Data Analysis, Grant Writing, Career Development in Research, and more.
🌟 *Our respected mentors are:* Dr. Syeda Sadaf Akber, Dr. Mudassar Azhar, Dr. Munsif Ali Jatoi, Dr. Muhammad Ali, Dr. Nimra Mazhar
🌟 *Highlights:* Publication opportunities, symposiums, personalized feedback, certification, and abstract book publication.

Who can participate: MBBS, BDS, PHARM D, DPT, B.Sc, M.Sc, M.Phil, Ph.D, and allied health science students.

📆 Deadline: August 5, 2024
🎓 Program Start: August 9, 2024

📍 Early Bird Registration Available!
📍 Apply Now: https://forms.gle/atED2JKsKYBqXtce8

For queries, contact us on WhatsApp: +92303-3256166

06/05/2024

*OPPORTUNITY FOR YOUR RESEARCH PROJECT TO BE FEATURED ON RESEARCH MINDS' SCIENCE FOR EVERYONE SHOW ON METRO 1 NEWS TV CHANNEL*

Research Minds invites schools, colleges, and universities to showcase their research projects on their TV show *Science for Everyone*, aired on Metro 1 News.

The show includes panel discussions, project exhibitions, quizzes and puzzles, exciting rewards, and funding opportunities, and features renowned scientists and industry experts who share valuable insights.

Submit your projects now and mark your calendars for July 20-21. Don't miss out!

To submit your project, register via:

https://forms.gle/UY5fnSsEirCHr9ZL8

and email the filled Project Template document (attached) to [email protected].

For queries, contact:
Wania Tabraiz +92 3022255563
Noor-ul-Huda +92 3051121700

28/03/2024

Embark on a transformative journey into the world of scientific writing with our premier four-week online course! Led by a stellar lineup of renowned researchers including
1.*Dr. Abdul Rasheed Khanzai (USA) ,*
2.*Dr. Muhammad Tanweer Khan (MTK) (Sweden)*
3.*Dr. Sama Mukhtar (Indus hospital)*
4.*Dr.Muhammad Ali, (Salim Habib University),*
5 *Dr. Raahim Ali, (USA)*
6.*Engr. Farhan Ahmad (UK)*
7.*Ms. Sania Bashir*
this intensive program is your ticket to mastering every aspect of research writing, from pattern methods to thesis writing. Don't miss this exclusive opportunity to learn from the best and unleash your full potential. Secure your spot now and join us on a path to excellence💫 Scan the QR code to register☄️

https://forms.gle/krduCebJoB78vevx6

Photos from Pharmacy and Pharmaceutical sciences lectures and notes by Dr. Muhammad Ali's post 03/12/2022

Scope of Pharmacy field

21/10/2022
21/10/2022

ایک دن پروفیسر صاحب سے جوتا پالش کرنے والے بچے نے جوتا پالش کرتے کرتے پوچھا
’’ماسٹر صاحب! کیا میں بھی بڑا آدمی بن سکتا ہوں‘‘
پروفیسر نے قہقہہ لگا کر جواب دیا
’’دنیا کا ہر شخص بڑا آدمی بن سکتا ہے‘‘
بچے کا اگلا سوال تھا

’’کیسے؟‘‘

پروفیسر نے اپنے بیگ سے چاک نکالا‘اوراسکےکھوکھے کی دیوار پر
دائیں سے بائیں تین لکیریں لگائیں‘

پہلی لکیر پر محنت‘ محنت اور محنت لکھا‘

دوسری لکیر پر ایمانداری‘ ایمانداری اور ایمانداری لکھا

اور تیسری لکیر پر صرف ایک لفظ ہنر )Skill( لکھا۔

بچہ پروفیسر کو چپ چاپ دیکھتا رہا‘ پروفیسر یہ لکھنے کے بعد بچے کی طرف مڑا اور بولا:

ترقی کے تین زینے ہوتے ہیں‘

پہلا زینہ محنت ہے.
آپ جو بھی ہیں‘ آپ اگر صبح‘ دوپہر اور شام تین اوقات میں محنت کر سکتے ہیں تو آپ تیس فیصد کامیاب ہو جائیں گے.
آپ کوئی سا بھی کام شروع کر دیں، آپ کی دکان‘ فیکٹری‘ دفتر یا کھوکھا صبح سب سے پہلے کھلنا چاہئے اور رات کو آخر میں بند ہونا چاہئے‘

آپ کامیاب ہو جائیں گے‘‘۔

پروفیسر نے کہا ’’ہمارے اردگرد موجود نوے فیصد لوگ سست ہیں‘ یہ محنت نہیں کرتے‘ آپ جوں ہی محنت کرتے ہیں آپ نوے فیصد سست لوگوں کی فہرست سے نکل کر دس فیصد محنتی لوگوں میں آ جاتے ہیں‘ آپ ترقی کیلئے اہل لوگوں میں شمار ہونے لگتے ہیں".

اگلا مرحلہ ایمانداری ہوتی ہے.

ایمانداری چار عادتوں کا پیکج ہے.

وعدے کی پابندی‘ جھوٹ سے نفرت‘ زبان پر قائم رہنا اور اپنی غلطی کا اعتراف کرنا۔

آپ محنت کے بعد ایمانداری کو اپنی زندگی کا حصہ بنا لو‘ وعدہ کرو تو پورا کرو‘ جھوٹ کسی قیمت پر نہ بولو‘

زبان سے اگر ایک بار بات نکل جائے تو آپ اس پر ہمیشہ قائم رہو اور ہمیشہ اپنی غلطی‘ کوتاہی اور خامی کا آگے بڑھ کر اعتراف کرو‘

تم ایماندار ہو جاؤ گے۔

کاروبار میں اس ایمانداری کی شرح 50 فیصد ہوتی ہے.

آپ پہلا تیس فیصد محنت سے حاصل کرتے ہیں. آپ کو دوسرا پچاس فیصد ایمانداری دیتی ہے.

اور پیچھے رہ گیا 20 فیصد تو یہ 20 فیصد ہنر ہوتا ہے.

آپ کا پروفیشنل ازم‘ آپ کی سکل اور آپ کا ہنر آپ کو باقی 20 فیصد بھی دے دے گا.

"آپ سو فیصد کامیاب ہو جاؤ گے‘‘.

پروفیسر نے بچے کو بتایا۔

’’لیکن یہ یاد رکھو ہنر‘ پروفیشنل ازم اور سکل کی شرح صرف 20 فیصد ہے اور یہ 20 فیصد بھی آخر میں آتا ہے‘ آپ کے پاس اگر ہنر کی کمی ہے تو بھی آپ محنت اور ایمانداری سے 80 فیصد کامیاب ہو سکتے ہیں.

لیکن یہ نہیں ہو سکتا کہ آپ بے ایمان اور سست ہوں اور آپ صرف ہنر کے زور پر کامیاب ہو جائیں۔

آپ کو محنت ہی سے سٹارٹ لینا ہو گا‘
ایمانداری کو اپنا اوڑھنا اور بچھونا بنانا ہو گا'
آخر میں خود کو ہنر مند ثابت کرنا ہوگا‘‘۔

پروفیسر نے بچے کو بتایا۔

"میں نے دنیا کے بے شمار ہنر مندوں اور فنکاروں کو بھوکے مرتے دیکھا‘

کیوں؟

کیونکہ وہ بے ایمان بھی تھے اور سست بھی'

اور میں نے دنیا کے بے شمار بےہنروں کو ذاتی جہاز اڑاتے دیکھا‘-

’تم ان تین لکیروں پر چلنا شروع کر دو‘
تم آسمان کی بلندیوں کو چھونے لگو گے‘‘۔

14/08/2022

IMPORTANT TERMINOLOGIES
SURGICAL TERMS

1. Amputation:
Removal of a limb or other appendage of the body
2. Exploratory
Investigation or examination for diagnostic purpose
3. Hydatid
Cyst like structure
4. Hydatid cyst
The larval cyst stage of the tape worm echinococcus granulous and E. multicularis, containing daughter cyst
with many scoloces(the attachment organ of a tape worm)
5. Ligation
The application of a ligature
6. Tubular ligation
Sterilization of the female by constricting severing or crushing the uterine
7. Cholecystectomy
Excision of the gall bladder
8. Appendectomy
Excision of the vermiform appendix
9. Appendicitis
Inflammation of the vermiform appendix
10. Acute
Appendicitis if acute onset requiring prompt surgery and usual marked by pain in their lower abdominal
quadrant referred rebound tenderness, overlying musclespasm and cutaneous hyperesthesia
11. Hernia
Protrusion of a portion of an organ or tissue through an abdominal opening
12. Incisional hernia
One occurring through an old abdominal incision
13. Inguinal
Hernia into the inguinal canal
14. Umbilical
Herniation of part of the umbilicus the in the abdominal wall and protruding bowel being covered with skin and subcutaneous tissue
15. Fistula
An abnormal passage between two internal organs or from an internal organ to the body surface
16. Arteriovenous
Between an artery and a vein
17. Laparotomy
Incision through the flank or more generally through any part of the abdominal wall
18. Ileostomy
Surgical creation of an opening into the ileum with a stoma on the abdominal wall
19. Stoma
Mouth like opening particularly an increased opening which is kept open for the purpose of drainage
20. Omentum
A fold of peritoneum extending from the stomach to adjacent abdominal organ
21. Colectomy
Excision of the colon or portion of it
22. Stricture
Stenosis narrowing of the duct or canal
23. Lobectomy
Excision of the lobe
24. Isthemectomy
Excision of an isthmus, asp isthmus of thyroid
25. Isthmus
A narrow connection between two large or parts
26. Diverticulum
A circumscribed pouch or sac occurring normally or created by herniation of the lining mucous membrane through a defect in the muscle coat of a tubular organ
27. Diverticulosis
The presence of diverticular in the absence of inflammation
28. Diverticulitis
Inflammation of a diverticulum
29. Suture
A stitch or series of stitches made to secure apposition of the edge of a surgical or traumatic around
30. Acute intussusceptions
One portion of the gut become invagination into another immediately adjacent, almost always it is proximal into distal (very rarely retrograde)
31. Volvulus
Axial rotation of the portion of the alimentary tract or is complete twisting of a bowel loop about its mesenteric base
32. Adhesion
Refers to localized peritoneal inflammation after surgery infection endometriosis or radiation healing leads to fibrous bridges between
Terms Used in Hospital/ Clinical Pharmacy
1. Arteriosclerosis
A group of disease characterized by thicken and loss of elasticity of the arterial walls, occurring in three forms, atherosclerosis, arteriolosclerosis and monckeberg’s arteriosclerosis.
2. Embolism
The sudden clocking of an artery by a clot or foreign material which has been brought to its site of lodgment by the blood current.
3. Embolus
A mass of clotted blood or other material brought by the blood from one vessel and forced into smaller one, obstructing the circulation
4. Fibrosis
Abnormal formation of fibrous tissue due to previous infection
5. Biopsy
Removal and examination usually microscopic tissue from the living body, performed to establish precise diagnosis
6. Calculus
An abnormal concretion) inorganic mass in the cavity or tissue) usually composed of mineral salts, occurring within the animal body.
7. Angina pectoris
Pain in the chest due to spasm of coronary vessel OR paroxysmal pain in the chest often radiating to the arm, particularly left usually due to interference with the supply of oxygen to the heart muscle and precipitated by excitement or effort
8. Atherosclerosis
Form arteriosclerosis in which a theoromas containing cholesterol, lipoid material and lipophages are formed within the intima and inner media of large and medium sized arteries
9. Stroke
A profound hemodynamic and metabolic disturbance due to failure of the circulatory system to maintain adequate perfusion of vital organs
10. Ischemia
Deficiency of blood in part, usually due to functional constriction or actual obstruction of blood
11. Stent
A slender or rod like or thread like device used to provide support for tubular structure that are being anastomosed, or to induce or maintain their patency
Or
A metallic support mounted on a balloon catheter, passed into an artery, stent is left in place to hold artery
12. Thrombosis
The formation or presence of clot during life is called thrombosis
13. Angiography
Radiography of the blood vessel after introduction of a contrast medium
14. Angioplasty
An angiographic procedure for elimination of areas of narrowing in the blood vessel
Or
An alternative to coronary bypass, a balloon type catheter exert pressure on area of plague this opening a blocked area of vessel
15. Pericarditis
Inflammation of double membrane surrounding the heart
16. Enuresis
Involuntary discharge of urine during sleep at night
17. Bronchospasm
Spasmodic contraction of the smooth muscle of the bronchi as in asthma
18. Nephrology
The branch of science that deals with structure and function of kidney
19. Heart block
A type of arrhythmia disturbed conduction of impulse from atrium to ventricles
20. Reconstitution
Process of reform of a drug constitution / part of the drug by using suitable diluents e.g antibiotic
Or
Reconstituted drugs are used within specific time
21. Dispensing
Branch of pharmacy which deals with the preparation packing labeling of a drug product .it is also involving patient counseling
Or
It also define as filling of prescription
22. Ambulatory patient
Refers to patient not bedridden in a hospital or other inpatient setting and able to walk
Or
It is referred to the care given in physician office clinic health centers and other places where ambulatory patient usually go for health care
23. Patient counseling
It refers to giving adequate understanding information in drug use adverse effects precaution ets to patient by a pharmacist
 Activee.g. verbal
 Passivee.g. printed
24. Side effects
These are the effects which are produced apart from the therapeutic effects of a drug they may be beneficial or harmful
25. Hydro nephritis
Collection of fluid in the pelvis of kidney due obstruction of outflow
26. Nephrolithiasis
Presence of stones or calculi in the kidney
27. Claudicating
Cramp like pain in legs due to insufficient arterial blood supply to the muscle
28. Hernioplasty
Surgical repair of perinea sometime specifically by apposition and suturing of the edges of the defect
29. Emphysema
Pathological accumulation of air in tissue or organs
Or
A state in which alveoli of the lung become dilated possibly with the destruction of alveolar wall leading to large empty air space which are useless for gas exchange
30. Aneurysm
A sac formed by localized dilation of the wall or an artery a vein or the heart
31. Pharmaceutical care
It describe specific services activities through which an individual pharmacist cooperate with patient and other monitoring a therapeutic plan that will produce specific outcome fot the patient
32. CORE
 C Condition of patient
 O Outcome desired for that condition
 R Regimen selected to achieve outcome evaluation parameters
33. PRIME
 P Pharmaceutical problems
 R Risk to patient
 I Interaction
 M Mismatch b/w medication and patient needs
 E Efficacy
34. FARM
 F Finding
 A Assessment
 R Resolution
 M Monitoring
35. Idiosyncrasy
This term is used to describe usually unexpected and bizarre drug effects which cannot readily explained

14/08/2022

Patient Compliance and Non Compliance:

Introduction
Improving the overall global disease burden is no easy task. More so, with the number of increasing incidences of fatalities, it has become all the more important to stress upon the root causes of such conditions and treat them accordingly.
Compliance is the process whereby the patient follows the prescribed and dispensed regimen as intended by the prescriber and dispenser. It is defined as “the extent to which a person’s behavior (in terms of taking medications, following diets, or executing lifestyle changes) coincides with medical or health advice. Compliance with therapy is an indication of a positive behavior in which the patient is motivated sufficiently to adhere to the prescribed treatment because of a perceived self-benefit and positive outcome.
Compliance, Adherence, and Concordance
The terms compliance, adherence, and concordance are often used interchangeably in practice. While related, these terms have somewhat different meanings.
Compliance is defined as “the extent to which the patient’s behavior matches the prescriber’s recommendations.” Its use implies the “lack of patient involvement” and is associated with negative characteristics such as yielding and submission. The definition of compliance assumes that all medical advice and drugs given to the patient are good for the patient and that the patient should adjust his or her behavior to follow the therapeutic regimen.
Adherence is defined as “the extent to which the patient’s behavior matches the agreed recommendations from the prescriber.” It takes the definition of compliance one step further by stressing the need for agreement. In this context, the patient has the flexibility to decide whether to adhere to the doctor’s recommendations. Nonadherence is not associated with blame on the part of the patient.
The term concordance is different in that it relates to the behavior between the doctor and the patient, whereas adherence and compliance are used with respect to the medication-taking nature of the patient. It refers to an agreement that is reached after a discussion between the health care professional and the patient in which the health care professional respects the feelings and beliefs of the patient with regard to whether, when, and how the medications are to be taken.
Measurement of Compliance
Direct methods include various assays conducted using biological markers and tracer compounds to detect medication levels in the bodily fluids. These methods are more accurate than indirect ones but are costly and require close monitoring. Direct methods of measuring compliance are most practical in hospitals and other inpatient settings. A common problem encountered with the measurements is that they do not account for the variability of pharmacokinetic factors of different medications and different individuals.
Indirect methods are subject to greater bias and are not as accurate as direct methods. These include interviews, diaries, pill counts, prescription filling dates, and therapeutic and preventive outcome measures. Patient self-reports and family interviews are highly
subjective and tend to overestimate compliance, but may provide useful data in customizing that patient’s medication. Pill counts are useful in assessing about 80% of true compliance, but they encourage pill dumping. Prescription refill dates are only accurate if the patient uses the same pharmacy to fill prescriptions and the database is accurate. However, filling a prescription on time does not necessarily mean that the patient is taking the medication correctly, or taking it at all.
Using therapeutic outcomes to determine the degree of compliance may encourage what is known as the toothbrush effect (i.e., patients may load up on or adhere to medication regimens a few days before the next visit to their health care professional). Additionally, the condition of the patient may change due to factors other than the medication, and the resulting therapeutic outcome may be skewed. Medication event monitoring systems (MEMS) are newer, electronic forms of monitoring that note the time and date when a medication vial was opened. Once again, however, this may not necessarily mean the patient took the medication at the time the vial was opened.
When one seeks medical attention, the first and foremost task is handed upon the physician and/or the examiner to assess the patient’s medical history and then prescribe an appropriate personalized medical regimen. Be it infectious diseases, chronic conditions or metabolic disorders, prescription of medication is only the first step of proceedings. It is equally upon the patient, as much as it is upon the doctor and healthcare professionals examining him, to stick to his/her prescribed routine and get a follow-up check done on a regular basis.
Adherence: Adherence is defined as the degree to which a patient voluntarily integrates and collaborates with the healthcare provider in terms of instructions regarding dosage, timing
and frequency of medication and gets a refill of prescriptions whenever necessary - eventually leading to a better therapeutic outcome. A related term, ‘medication persistence’ is defined as the time from the initiation of therapy, till the time it is aborted, which might be the exact prescribed time span or a part of it.
I. Adherence and compliance are pivotal in ensuring an improved health outcome for the patient especially if he is suffering from a chronic condition and needs prolonged medical attention. Examples in this category include those with cardiovascular complications, diabetes and different forms of cancer.
II. Studies have found that patients with chronic conditions, post discharge from hospitals, mostly stop adhering to their medical routines by the end of the month, with very few patients reporting to continue with medications beyond 6 to 12months, depending on the particular class of drugs used.
III. Increasing non-adherence has been associated with adverse health outcomes, increased rates of morbidity and mortality and increased healthcare costs.
IV. Some of the major obstacles in patient adherence include overlapping medication regimes from constantly changing healthcare providers, lack of proper education and discontinuation of medication, knowingly or unknowingly, socio-economic barriers within populations and lack of family support, social stigma and discrimination.
V. An effective way to plummet the soaring healthcare costs is to invest a fraction of the projected healthcare costs into patient adherence and compliance programs and interventions instead of using them to come up with new medications and drug combinations, especially for patients with diabetic and cardiovascular complications, hypertension and cancer.
Factors related to non-adherence and non-compliance
Patient-related factors
1. Inadequate health literacy and knowledge (mostly in case of asymptomatic diseases).
2. Inadequate knowledge about the medical decision-making process.
3. Socio-economic status poses a threat towards bearing treatment costs which are often expensive and complicated.
4. Lack of communication and transportation, mostly in rural areas.
5. Lack of family support.
Physician-related factors
i. Prescribing complex medication regimes which are beyond the patient’s understanding.
ii. Lack of communication between different healthcare officials (eg. Hospital officials, nurses, general physicians and consultants during post-discharge visits).
iii. Inadequate knowledge about a patient’s disease background.
iv. Inadequate knowledge about a patient’s financial burden before prescribing any medication.
Health system-related factors
A. Fragmented healthcare systems, lack of co-ordination between healthcare providers, hinder a patient’s access to effective health care.
B. Health information technology, though looks promising, is laced with its own loopholes which hamper effective healthcare monitoring by doctors and healthcare professionals. Healthcare IT systems need to look at the bigger picture instead of focusing on proprietary and local needs.
C. Creating an effective electronic health record (EHR) would help manage most of the shortcomings of the healthcare IT system.
D. Insufficient interaction time between healthcare providers and patients.
Measures to increase adherence and compliance
a. Understand the root cause of non-adherence and plan appropriate interventions and interviews to bridge the gaps.
b. Increase patient literacy and educate patients to understand the underlying importance of adherence and compliance.
c. Self-reporting by patients, though economical and effective, have poor sensitivity and specificity. They often lead to over-estimation of their adherence and compliance to the prescribed routine. It might also lead to ‘stockpiling’ of medication, without actually using them effectively. Hence there lies a need to supplement these patient reports in order to ensure effective utilization of the prescribed drug regimen. Studies indicate that measures involving Electronic Medication Packaging (EMP) devices (like Medication Event Monitoring Systems, MEMS) and pill counts have been proved to be more accurate and effective.2,11
d. Countries with a centralized medical database should synchronize between care givers, prescribers, dispensers and patients regarding the refill of prescriptions and then feed data
into their systems, in order to have a uniform and unbiased electronic health record (HER) to ensure a patient’s medication regime and compliance. A consistent review of these prescription refill records increases specificity of the process.
e. Telemedicine is another evolving tool to bridge gaps in healthcare, and can be looked upon as a strong contender to spread awareness regarding the importance of adherence and compliance in both developing and developed countries.
f. Educate, empower and encourage the family members and supporters to help the patient stick to his/her prescribed routine.
g. Patients under single-dose therapy, intermittent administration or are hospitalized, can have their metabolite and drug concentration in body-fluids monitored, in order to correlate their dosing frequencies.
h. Patient-centric healthcare paradigms can be prescribed after assessing the patient’s behavioral psychology and medical history. Be it medication or lifestyle modifications, discussing with the patient on a one-on-one basis, and mutually agreeing on a regime (the evolving concept of ‘Shared Decision Making’) might also be beneficial in improving patient adherence and compliance.
i. Lastly, there are a set of questionnaires which help in evaluating the rates of adherence in patients, like the Eight Item Morisky Medication Adherence Scale, Hill-Bone Compliance scale, Brief Medication Questionnaire, Medication Adherence Report Scale. Combining patient interviews along with such questionnaires helps minimizing discrepancies in measurement of adherence and compliance. It is only when both sides (physician and patients) adhere and comply to the norms; one can hope to reduce the burden of diseases and lead a healthy and wholesome life.

14/08/2022

ANTIDOTES: ITS MECHANISM AND THERAPEUTIC USES

Toxicological emergencies are encountered frequently in intensive care unit (ICU) practice, either as a result of drug overdose (accidental or suicidal) or due to drug toxicity secondary to inappropriate drug dosing or drug interactions. In general, toxic agents can be classified into two groups: those for which specific treatment exists and others for which there is no specific therapy. Poisoning is very common in all human beings and to treat the poisoning the antidotes are used.
Antidotes An antidote is an agent which counteracts a poison. In the treatment of acute poisoning most patients require only supportive and symptomatic therapy. The active removal of poisons from the stomach by gastric lavage or emesis induction is done by the administration of substances like activated charcoal by mouth to reduce the absorption. Antidotes are agents that negate the effect of a poison or toxin. Antidotes mediate its effect either by preventing the absorption of the toxin, by binding and neutralizing the poison, antagonizing its end-organ effect, or by inhibition of conversion of the toxin to more toxic metabolites. Antidote administration may not only result in the reduction of free or active toxin level, but also in the mitigation of end-organ effects of the toxin by mechanisms that include competitive inhibition, receptor blockade or direct antagonism of the toxin. The International Program of Chemical Safety broadly defines an antidote as a therapeutic agent that counteracts the toxic actions of a drug/toxin. Broadly, antidotes have been looked at as agents that “modify the kinetics of the toxic substance or interfere with its effect at receptor sites.” This may be as a result of prevention of absorption, binding, and neutralizing the poison
directly, antagonizing its end-organ effect, or inhibition of conversion to more toxic metabolites. A chemical's safety is defined by its therapeutic index or ratio (TD50/ED50), which is the ratio of the toxic dose (TD) or lethal dose (LD) to the effective dose (ED). Based on this, an antidote has also been defined as an agent that “increases the mean lethal dose of a toxin.” Techniques used to promote the elimination of poisons from the body such as forced diuresis, hemodialysis, or hemoperfusion are employed for a limited number of poisons. There are some specific antidotes and their use in appropriate circumstances can be life-saving. Such use does not preclude relevant supportive and symptomatic treatment. Mechanism of Action of Antidotes Antidotes act by different mechanism. Reduction in free toxin level can be achieved by specific and non-specific agents that bind to the toxin. The most commonly used non-specific binding agent is activated charcoal. Specific binders include chelating agents, bioscavenger therapy and immunotherapy. The mechanisms of action of antidotes are given below:
1) Complex formation. 2) Metabolic conversion. 3) Prevention of toxic metabolite formation. 4) By changing the physio-chemical nature of toxicant. 5) Promotes return to normal function by repairing a defect or enhancing a function that corrects the effects of poison.
Classification of Antidotes Depending on their action, antidotes are classified as: 1) Chemical Antidotes: Chemical antidotes are the agents which change the chemical nature of poison. For example, sodium thiosulphate which changes toxic cyanide to the non-toxic thiocyanate; sodium calcium edetate chelates agents used for heavy metal poison. 2) Physiological Antidotes: Physiological antidotes act by producing the effect opposite to that of poison. For example, sodium nitrite converts hemoglobin into methemoglobin in order to bind cyanide. 3) Mechanical Antidotes: Mechanical antidotes which prevent the absorption of poison into the body. For example, activated charcoal absorbs the poison prior to absorption across intestinal wall. Copper sulphate, magnesium sulphate and sodium monohydrogen phosphate inactivate and precipitate the toxic material as insoluble salts by chelation.
Therapeutic Uses Antidotes are used in treatment of poisoning as well as in case of over dose of drugs. Following are the examples of antidotes which are used for treating poisoning: Examples of Poisons and Antidotes Poison/Drug (Antidote) Paracetamol (acetaminophen) (N-acetylcysteine) Anticoagulants, E.G., Warfarin (Vitamin K)
Opioids (Naloxone) Iron (and other heavy metals) (Desferrioxamine, Deferasirox or Deferiprone) Benzodiazepines (Flumazenil) Ethylene Glycol (Ethanol, Fomepizole or Thiamine) Methanol (Ethanol or Fomepizole) Cyanide (Amyl Nitrite, Sodium Nitrite and Sodium Thiosulfate) Organophosphates (Atropine and Pralidoxime) Magnesium (Calcium Gluconate) Calcium Channel Blockers (Verapamil, Diltiazem) (Calcium Gluconate) Beta-Blockers Propranolol, Sotalol) (Calcium Gluconate and/or Glucagon) Isoniazid (Pyridoxine) Atropine (Physostigmine)

Want your school to be the top-listed School/college in Karachi?

Click here to claim your Sponsored Listing.

Location

Category

Website

Address


Karachi